169 related articles for article (PubMed ID: 16896545)
1. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.
Afantitis A; Melagraki G; Sarimveis H; Koutentis PA; Markopoulos J; Igglessi-Markopoulou O
Mol Divers; 2006 Aug; 10(3):405-14. PubMed ID: 16896545
[TBL] [Abstract][Full Text] [Related]
2. QSAR for anti-HIV activity of HEPT derivatives.
Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
[TBL] [Abstract][Full Text] [Related]
3. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
Douali L; Villemin D; Zyad A; Cherqaoui D
Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
[TBL] [Abstract][Full Text] [Related]
4. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
5. Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
Curr Pharm Des; 2003; 9(22):1817-26. PubMed ID: 12871199
[TBL] [Abstract][Full Text] [Related]
6. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters.
Gayen S; Debnath B; Samanta S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923
[TBL] [Abstract][Full Text] [Related]
7. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
Kireev DB; Chrétien JR; Grierson DS; Monneret C
J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
[TBL] [Abstract][Full Text] [Related]
8. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method.
Toropova AP; Toropov AA; Veselinović JB; Miljković FN; Veselinović AM
Eur J Med Chem; 2014 Apr; 77():298-305. PubMed ID: 24657566
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary optimization, backpropagation, and data preparation issues in QSAR modeling of HIV inhibition by HEPT derivatives.
Weekes D; Fogel GB
Biosystems; 2003 Nov; 72(1-2):149-58. PubMed ID: 14642664
[TBL] [Abstract][Full Text] [Related]
10. QSAR based on multiple linear regression and PLS methods for the anti-HIV activity of a large group of HEPT derivatives.
Luco JM; Ferretti FH
J Chem Inf Comput Sci; 1997; 37(2):392-401. PubMed ID: 9090857
[TBL] [Abstract][Full Text] [Related]
11. Non-nucleoside HIV-1 reverse transcriptase inhibitors, Part 7. Synthesis, antiviral activity, and 3D-QSAR investigations of novel 6-(1-naphthoyl) HEPT analogues.
Ji L; Chen FE; Feng XQ; De Clercq E; Balzarini J; Pannecouque C
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1248-53. PubMed ID: 16946529
[TBL] [Abstract][Full Text] [Related]
12. HEPT derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase: QSAR studies agree with the crystal structures.
Gaudio AC; Montanari CA
J Comput Aided Mol Des; 2002 Apr; 16(4):287-95. PubMed ID: 12400858
[TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationship study on the anti-HIV-1 activity of novel 6-naphthylthio HEPT analogs.
Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
Chem Biol Drug Des; 2009 Aug; 74(2):165-72. PubMed ID: 19549086
[TBL] [Abstract][Full Text] [Related]
14. Use of artificial neural networks in a QSAR study of anti-HIV activity for a large group of HEPT derivatives.
Jalali-Heravi M; Parastar F
J Chem Inf Comput Sci; 2000; 40(1):147-54. PubMed ID: 10661561
[TBL] [Abstract][Full Text] [Related]
15. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Lawtrakul L; Hannongbua S; Beyer A; Wolschann P
Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434
[TBL] [Abstract][Full Text] [Related]
16. 4D-QSAR study of HEPT derivatives by electron conformational-genetic algorithm method.
Akyüz L; Sarıpınar E; Kaya E; Yanmaz E
SAR QSAR Environ Res; 2012 Jul; 23(5-6):409-33. PubMed ID: 22452710
[TBL] [Abstract][Full Text] [Related]
17. Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors.
Pungpo P; Hannongbua S; Wolschann P
Curr Med Chem; 2003 Sep; 10(17):1661-77. PubMed ID: 12871115
[TBL] [Abstract][Full Text] [Related]
18. Application of ant colony optimization in development of models for prediction of anti-HIV-1 activity of HEPT derivatives.
Zare-Shahabadi V; Abbasitabar F
J Comput Chem; 2010 Sep; 31(12):2354-62. PubMed ID: 20575016
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.
Solov'ev VP; Varnek A
J Chem Inf Comput Sci; 2003; 43(5):1703-19. PubMed ID: 14502505
[TBL] [Abstract][Full Text] [Related]
20. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
